{"Symbol": "AMGN", "AssetType": "Common Stock", "Name": "Amgen Inc", "Description": "Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.", "CIK": "318154", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)", "Address": "ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US", "OfficialSite": "https://www.amgen.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "149682045000", "EBITDA": "15157000000", "PERatio": "36.78", "PEGRatio": "0.939", "BookValue": "10.95", "DividendPerShare": "9", "DividendYield": "0.0342", "EPS": "7.57", "RevenuePerShareTTM": "62.24", "ProfitMargin": "0.122", "OperatingMarginTTM": "0.518", "ReturnOnAssetsTTM": "0.064", "ReturnOnEquityTTM": "0.675", "RevenueTTM": "33423999000", "GrossProfitTTM": "22966000000", "DilutedEPSTTM": "7.57", "QuarterlyEarningsGrowthYOY": "-0.187", "QuarterlyRevenueGrowthYOY": "0.109", "AnalystTargetPrice": "316.23", "AnalystRatingStrongBuy": "5", "AnalystRatingBuy": "10", "AnalystRatingHold": "14", "AnalystRatingSell": "2", "AnalystRatingStrongSell": "1", "TrailingPE": "36.78", "ForwardPE": "13.39", "PriceToSalesRatioTTM": "4.478", "PriceToBookRatio": "25.45", "EVToRevenue": "5.91", "EVToEBITDA": "14.8", "Beta": "0.581", "52WeekHigh": "338.98", "52WeekLow": "251.27", "50DayMovingAverage": "303.12", "200DayMovingAverage": "305.28", "SharesOutstanding": "537205000", "DividendDate": "2025-06-06", "ExDividendDate": "2025-05-16"}